Literature DB >> 16995797

Suppression of genes related to hypertrophy and osteogenesis in committed human mesenchymal stem cells cultured on novel nitrogen-rich plasma polymer coatings.

Fackson Mwale1, Pierre-Luc Girard-Lauriault, Hong Tian Wang, Sophie Lerouge, John Antoniou, Michael R Wertheimer.   

Abstract

Mesenchymal stem cells (MSCs) are pluripotent progenitor cells with the ability to generate cartilage, bone, muscle, tendon, ligament, and fat. However, recent evidence indicates that a major drawback of current cartilage- and intervertebral disc-tissue engineering is that human MSCs isolated from some arthritic patients (a clinically relevant source of stem cells) express type X collagen (a marker of chondrocyte hypertrophy associated with endochondral ossification) and osteogenic markers. Some studies have attempted to use growth factors to inhibit type X collagen expression, but none has addressed the possible effect of the chemical composition of the substratum on chondrocyte hypertrophy and osteogenesis. Here, we examine the growth and differentiation potential of human MSCs cultured on nitrogen (N)-rich plasma polymer layers (N-doped plasma-polymerized ethylene, containing up to 36% nitrogen; PPE:N). We show that PPE:N almost completely suppresses the expression not only of type X collagen, but also of osteogenic marker genes such as alkaline phosphatase, bone sialoprotein, and osteocalcin. In contrast, neither aggrecan nor type I collagen expression were significantly affected. These results indicate that PPE:N coatings may be suitable surfaces for inducing MSCs to a chondrocyte or disc-like phenotype for tissue engineering of cartilage or intervertebral discs, in which hypertrophy and osteogenesis are suppressed.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16995797     DOI: 10.1089/ten.2006.12.2639

Source DB:  PubMed          Journal:  Tissue Eng        ISSN: 1076-3279


  26 in total

1.  Structured three-dimensional co-culture of mesenchymal stem cells with meniscus cells promotes meniscal phenotype without hypertrophy.

Authors:  Xiaofeng Cui; Akihiko Hasegawa; Martin Lotz; Darryl D'Lima
Journal:  Biotechnol Bioeng       Date:  2012-03-22       Impact factor: 4.530

Review 2.  Mesenchymal stem cells as a potent cell source for articular cartilage regeneration.

Authors:  Mohamadreza Baghaban Eslaminejad; Elham Malakooty Poor
Journal:  World J Stem Cells       Date:  2014-07-26       Impact factor: 5.326

3.  Mechanical loading inhibits hypertrophy in chondrogenically differentiating hMSCs within a biomimetic hydrogel.

Authors:  E A Aisenbrey; S J Bryant
Journal:  J Mater Chem B       Date:  2016-03-15       Impact factor: 6.331

4.  Chondrogenic differentiation of human bone marrow-derived mesenchymal stem cells treated by GSK-3 inhibitors.

Authors:  Mohamadreza Baghaban Eslaminejad; Negar Karimi; Maryam Shahhoseini
Journal:  Histochem Cell Biol       Date:  2013-07-10       Impact factor: 4.304

5.  Temporal activation of β-catenin signaling in the chondrogenic process of mesenchymal stem cells affects the phenotype of the cartilage generated.

Authors:  Zheng Yang; Yu Zou; Xi Min Guo; Hwee San Tan; Vinitha Denslin; Chen Hua Yeow; Xia Fei Ren; Tong Ming Liu; James Hp Hui; Eng Hin Lee
Journal:  Stem Cells Dev       Date:  2012-01-17       Impact factor: 3.272

6.  Hypertrophy in mesenchymal stem cell chondrogenesis: effect of TGF-beta isoforms and chondrogenic conditioning.

Authors:  Michael B Mueller; Maria Fischer; Johannes Zellner; Arne Berner; Thomas Dienstknecht; Lukas Prantl; Richard Kujat; Michael Nerlich; Rocky S Tuan; Peter Angele
Journal:  Cells Tissues Organs       Date:  2010-04-20       Impact factor: 2.481

7.  Naproxen induces type X collagen expression in human bone-marrow-derived mesenchymal stem cells through the upregulation of 5-lipoxygenase.

Authors:  Abdulrahman M Alaseem; Padma Madiraju; Sultan A Aldebeyan; Hussain Noorwali; John Antoniou; Fackson Mwale
Journal:  Tissue Eng Part A       Date:  2014-10-23       Impact factor: 3.845

8.  An in vitro study investigating the survival and phenotype of mesenchymal stem cells following injection into nucleus pulposus tissue.

Authors:  Christine L Le Maitre; Pauline Baird; Anthony J Freemont; Judith A Hoyland
Journal:  Arthritis Res Ther       Date:  2009-02-11       Impact factor: 5.156

Review 9.  Chondrogenic differentiation of mesenchymal stem cells: challenges and unfulfilled expectations.

Authors:  Rodrigo A Somoza; Jean F Welter; Diego Correa; Arnold I Caplan
Journal:  Tissue Eng Part B Rev       Date:  2014-05-27       Impact factor: 6.389

10.  Functional characterization of hypertrophy in chondrogenesis of human mesenchymal stem cells.

Authors:  Michael B Mueller; Rocky S Tuan
Journal:  Arthritis Rheum       Date:  2008-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.